| Phase 3 |
| NCT06246916 |
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants… |
Melanoma |
Recruiting |
| NCT05352672 |
Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in… |
Melanoma |
Active, Not Recruiting |
| Phase 2/3 |
| NCT05785767 |
A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is… |
Advanced Non-Small Cell Lung Cancer |
Active, Not Recruiting |
| NCT05800015 |
A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works… |
Non-small Cell Lung Cancer |
Active, Not Recruiting |
| Phase 2 |
| NCT06918132 |
Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell… |
Lung Non-Small Cell Carcinoma |
Recruiting |
| NCT07223541 |
Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell… |
Clear Cell Renal Cell Carcinoma |
Recruiting |
| NCT06699602 |
A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma |
Renal Cell Carcinoma |
Recruiting |
| NCT06865339 |
Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small… |
NSCLC |
Recruiting |
| NCT07188896 |
A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus… |
Advanced Renal Cell Carcinoma (aRCC) |
Recruiting |
| NCT06205836 |
Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally… |
Colorectal Cancer |
Recruiting |
| NCT06594991 |
A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma |
Advanced Melanoma |
Recruiting |
| NCT06787612 |
Investigation of Ubamatamab Combination Therapy in Adult Participants With… |
Ovarian Cancer |
Recruiting |
| NCT07346196 |
A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck |
Squamous Cell Carcinoma |
Not Yet Recruiting |
| NCT07234058 |
Trial Assessing Fianlimab Plus Cemiplimab Plus Chemotherapy or Cemiplimab Plus… |
Pleural Mesotheliomas |
Not Yet Recruiting |
| NCT03916627 |
Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult… |
Non-small Cell Lung Cancer |
Active, Not Recruiting |
| NCT07511036 |
PROSECCO: A Phase 2, Single Arm, Neoadjuvant Study Evaluating Combination Cemiplimab… |
Melanoma |
Not Yet Recruiting |
| NCT07281768 |
Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or… |
Colorectal Cancer |
Not Yet Recruiting |
| NCT06161441 |
A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe… |
Resectable Non-small Cell Lung Cancer |
Active, Not Recruiting |
| NCT07527325 |
Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma |
Melanoma (Skin) |
Not Yet Recruiting |
| Phase 1/2 |
| NCT04989946 |
Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint… |
Prostate Cancer |
Recruiting |
| Phase 1 |
| NCT05137054 |
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other… |
Multiple Myeloma |
Recruiting |
| NCT03233139 |
Safety and Pharmacokinetics of Cemiplimab Anti-programmed Death-ligand 1 (Anti-PD-1) and… |
Advanced Malignancies |
Active, Not Recruiting |